. METHOD FOR VIR MATERIAL CONCLUSION VIR may be an op.on for selected pa.ents. Cau.on is to be taken according to an.coagula.on and valve thrombosis. S.ll we do not know the durability of the THV especially in the mitral posi.on RESULTS Valve thrombosis and DegeneraAon aBer Transcatheter Mitral Valve ImplantaAon (V-i-R) Gry Dahle MD, Kjell Arne Rein MD,PhD, JT Offstad MD;PhD, Arnt Fiane , MD,PhD Rikshospitalet, OUS, Oslo, Norway INTRODUCTION Valve-in-valve (VIV) and valve-in-ring (VIR) are established methods for degenerated bioprostheses and failed repairs. There are reports on thrombosis and degenera.on of transcatheter heart valves (THV) in na.ve valve posi.on. This can also be an issue for the VIV/R procedures. We report one valve thrombosis and one THV degenera.on in mitral VIR PaAent 1 PaAent 2 Valve thrombosis Follow upfollowint sc.lysis and three months of coumadine INR 3-3.5 Follow up at 5 years gradient of 16mmHg At 4 years follow up only gradient of 6mmHg Now highly symptoma.c Procedure of VIV planned PaAent 2 PaAent 1
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
.
METHODFORVIR
MATERIAL
CONCLUSIONVIRmaybeanop.onforselectedpa.ents.Cau.onistobetakenaccordingtoan.coagula.onandvalvethrombosis.S.llwedonotknowthedurabilityoftheTHVespeciallyinthemitralposi.on
RESULTS
ValvethrombosisandDegeneraAonaBerTranscatheterMitralValveImplantaAon(V-i-R)
GryDahleMD,KjellArneReinMD,PhD,JTOffstadMD;PhD,ArntFiane,MD,PhDRikshospitalet,OUS,Oslo,Norway
INTRODUCTIONValve-in-valve(VIV)andvalve-in-ring(VIR)areestablishedmethodsfordegeneratedbioprosthesesandfailedrepairs.Therearereportsonthrombosisanddegenera.onoftranscatheterheartvalves(THV)inna.vevalveposi.on.ThiscanalsobeanissuefortheVIV/Rprocedures.WereportonevalvethrombosisandoneTHVdegenera.oninmitralVIR
PaAent1
PaAent2 Valvethrombosis
Followupfollowintsc.lysisandthreemonthsofcoumadineINR3-3.5
Followupat5yearsgradientof16mmHgAt4yearsfollowuponlygradientof6mmHgNowhighlysymptoma.cProcedureofVIVplanned
PaAent2PaAent1
Related Documents
